Matthew R Orton Selected Research

Matthew R Orton Research Topics

9	Neoplasms (Cancer) 01/2022 - 04/2009
4	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2014
3	Neoplasm Metastasis (Metastasis) 12/2021 - 04/2012
2	Sarcoma (Soft Tissue Sarcoma) 11/2023 - 01/2022
1	Extranodal Extension 02/2024
1	Necrosis 04/2018
1	Hypoxia (Hypoxemia) 04/2018
1	Carcinoma (Carcinomatosis) 04/2018
1	Fibrosis (Cirrhosis) 04/2018
1	Glioma (Gliomas) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 07/2015
1	Starvation 01/2014
1	Colorectal Neoplasms (Colorectal Cancer) 10/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2012

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014 - 10/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2014 - 10/2013
2	Pyruvic Acid (Pyruvate)IBA 01/2014 - 10/2013
1	regorafenibIBA 12/2021
1	Phenobarbital (Luminal)FDA Link 01/2019
1	pimonidazoleIBA 04/2018
1	CollagenIBA 04/2018
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 04/2018
1	C.I. direct red 80IBA 04/2018
1	PI103IBA 01/2014
1	NAD (NADH)IBA 01/2014
1	Amino Acids FDA Link 01/2014
1	EnzymesIBA 10/2013
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2013
1	YttriumIBA 04/2012
1	Octreotide (Sandostatin)FDA LinkGeneric 04/2012
1	Peptide Receptors (Peptide Receptor)IBA 04/2012
1	Lapatinib (GW572016)FDA Link 04/2011

3	Radiotherapy 01/2022 - 03/2017
3	Therapeutics 01/2014 - 04/2009
2	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 03/2017
2	Aftercare (After-Treatment) 12/2021 - 04/2012
1	Neoadjuvant Therapy 11/2023
1	Drug Therapy (Chemotherapy) 07/2015